157 related articles for article (PubMed ID: 29254168)
101. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
102. Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer.
Zhou Q; Peng Y; Ji F; Chen H; Kang W; Chan LS; Gou H; Lin Y; Huang P; Chen D; Wei Q; Su H; Liang C; Zhang X; Yu J; Wong CC
Nat Commun; 2023 Aug; 14(1):4677. PubMed ID: 37542037
[TBL] [Abstract][Full Text] [Related]
103. Alteration of intracellular metabolome in osteosarcoma stem cells revealed by liquid chromatography-tandem mass spectrometry.
Zhong Z; Mao S; Lin H; Li H; Lin J; Lin JM
Talanta; 2019 Nov; 204():6-12. PubMed ID: 31357340
[TBL] [Abstract][Full Text] [Related]
104. Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer.
Xie H; Hou Y; Cheng J; Openkova MS; Xia B; Wang W; Li A; Yang K; Li J; Xu H; Yang C; Ma L; Li Z; Fan X; Li K; Lou G
Oncotarget; 2017 May; 8(19):32134-32146. PubMed ID: 28389631
[TBL] [Abstract][Full Text] [Related]
105. KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.
Wen Q; Dunne PD; O'Reilly PG; Li G; Bjourson AJ; McArt DG; Hamilton PW; Zhang SD
Oncotarget; 2017 Jan; 8(2):3206-3225. PubMed ID: 27965461
[TBL] [Abstract][Full Text] [Related]
106. Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells.
Wang C; Ruan P; Zhao Y; Li X; Wang J; Wu X; Liu T; Wang S; Hou J; Li W; Li Q; Li J; Dai F; Fang D; Wang C; Xie S
Oncotarget; 2017 Jan; 8(1):1092-1109. PubMed ID: 27901475
[TBL] [Abstract][Full Text] [Related]
107. Determination of amino acids in colon cancer cells by using UHPLC-MS/MS and [U-
Li X; Wong CC; Tang Z; Wu J; Li S; Qian Y; Xu J; Yang Z; Shen Y; Yu J; Cai Z
Talanta; 2017 Jan; 162():285-292. PubMed ID: 27837831
[TBL] [Abstract][Full Text] [Related]
108. Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase.
Toda K; Kawada K; Iwamoto M; Inamoto S; Sasazuki T; Shirasawa S; Hasegawa S; Sakai Y
Neoplasia; 2016 Nov; 18(11):654-665. PubMed ID: 27764698
[TBL] [Abstract][Full Text] [Related]
109. Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis.
Xia J; Wishart DS
Curr Protoc Bioinformatics; 2016 Sep; 55():14.10.1-14.10.91. PubMed ID: 27603023
[TBL] [Abstract][Full Text] [Related]
110. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion.
Sousa CM; Biancur DE; Wang X; Halbrook CJ; Sherman MH; Zhang L; Kremer D; Hwang RF; Witkiewicz AK; Ying H; Asara JM; Evans RM; Cantley LC; Lyssiotis CA; Kimmelman AC
Nature; 2016 Aug; 536(7617):479-83. PubMed ID: 27509858
[TBL] [Abstract][Full Text] [Related]
111. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
112. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor.
Krall AS; Xu S; Graeber TG; Braas D; Christofk HR
Nat Commun; 2016 Apr; 7():11457. PubMed ID: 27126896
[TBL] [Abstract][Full Text] [Related]
113. Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients.
Hsu HC; Thiam TK; Lu YJ; Yeh CY; Tsai WS; You JF; Hung HY; Tsai CN; Hsu A; Chen HC; Chen SJ; Yang TS
Oncotarget; 2016 Apr; 7(16):22257-70. PubMed ID: 26989027
[TBL] [Abstract][Full Text] [Related]
114. Metabolomics: beyond biomarkers and towards mechanisms.
Johnson CH; Ivanisevic J; Siuzdak G
Nat Rev Mol Cell Biol; 2016 Jul; 17(7):451-9. PubMed ID: 26979502
[TBL] [Abstract][Full Text] [Related]
115. Emerging applications of metabolomics in drug discovery and precision medicine.
Wishart DS
Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202
[TBL] [Abstract][Full Text] [Related]
116. Dietary polyamine intake and colorectal cancer risk in postmenopausal women.
Vargas AJ; Ashbeck EL; Wertheim BC; Wallace RB; Neuhouser ML; Thomson CA; Thompson PA
Am J Clin Nutr; 2015 Aug; 102(2):411-9. PubMed ID: 26135350
[TBL] [Abstract][Full Text] [Related]
117. Metabolism links bacterial biofilms and colon carcinogenesis.
Johnson CH; Dejea CM; Edler D; Hoang LT; Santidrian AF; Felding BH; Ivanisevic J; Cho K; Wick EC; Hechenbleikner EM; Uritboonthai W; Goetz L; Casero RA; Pardoll DM; White JR; Patti GJ; Sears CL; Siuzdak G
Cell Metab; 2015 Jun; 21(6):891-7. PubMed ID: 25959674
[TBL] [Abstract][Full Text] [Related]
118. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Ferlay J; Soerjomataram I; Dikshit R; Eser S; Mathers C; Rebelo M; Parkin DM; Forman D; Bray F
Int J Cancer; 2015 Mar; 136(5):E359-86. PubMed ID: 25220842
[TBL] [Abstract][Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
